BCAX (Bicara Therapeutics) FFO per Share


BCAX Bicara Therapeutics Inc BCAX
12 GF Score
Price $28.01
! 3 Warning Signs
View Full Analysis

What is Bicara Therapeutics FFO per Share?

FFO per Share only applies to REITs.

BCAX
12GF Score
Bicara Therapeutics Inc BCAX
FFO per Share is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Bicara Therapeutics Business Description

Address 116 Huntington Avenue, Suite 703, Boston, MA, USA, 02116
Bicara Therapeutics Inc is a clinical-stage biopharmaceutical company bringing transformative bifunctional therapies to patients with solid tumors. Its program ficerafusp alfa is a bifunctional antibody that combines two clinically validated targets, an epidermal growth factor receptor, or EGFR, directed monoclonal antibody with a domain that binds to human transforming growth factor beta, or TGF-b. The company's goal is to build a fully integrated, commercial-stage biopharmaceutical company that develops important therapies for people living with cancer, starting with ficerafusp alfa.
12GF Score

Get the complete analysis for BCAX

FFO per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$28.01
Price